• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞生长因子受体被鉴定为c-met原癌基因产物。

Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.

作者信息

Bottaro D P, Rubin J S, Faletto D L, Chan A M, Kmiecik T E, Vande Woude G F, Aaronson S A

机构信息

Laboratory of Cellular and Molecular Biology, National Cancer Institute, Bethesda, MD 20892.

出版信息

Science. 1991 Feb 15;251(4995):802-4. doi: 10.1126/science.1846706.

DOI:10.1126/science.1846706
PMID:1846706
Abstract

Hepatocyte growth factor (HGF) is a plasminogen-like protein thought to be a humoral mediator of liver regeneration. A 145-kilodalton tyrosyl phosphoprotein observed in rapid response to HGF treatment of intact target cells was identified by immunoblot analysis as the beta subunit of the c-met proto-oncogene product, a membrane-spanning tyrosine kinase. Covalent cross-linking of 125I-labeled ligand to cellular proteins of appropriate size that were recognized by antibodies to c-met directly established the c-met product as the cell-surface receptor for HGF.

摘要

肝细胞生长因子(HGF)是一种类似纤溶酶原的蛋白质,被认为是肝脏再生的体液介质。通过免疫印迹分析确定,在完整靶细胞经HGF处理后迅速出现的一种145千道尔顿的酪氨酰磷酸化蛋白是原癌基因c-met产物的β亚基,c-met是一种跨膜酪氨酸激酶。将125I标记的配体与能被c-met抗体识别的合适大小的细胞蛋白进行共价交联,直接证实了c-met产物是HGF的细胞表面受体。

相似文献

1
Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.肝细胞生长因子受体被鉴定为c-met原癌基因产物。
Science. 1991 Feb 15;251(4995):802-4. doi: 10.1126/science.1846706.
2
The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells.Met受体酪氨酸激酶在上皮细胞中传导分散因子/肝细胞生长因子的运动性、增殖和形态发生信号。
J Cell Biol. 1993 Apr;121(1):145-54. doi: 10.1083/jcb.121.1.145.
3
Characterization of hepatocyte-growth-factor receptors on Meth A cells.甲种肉瘤(Meth A)细胞上肝细胞生长因子受体的特性分析
Eur J Biochem. 1992 Mar 1;204(2):857-64. doi: 10.1111/j.1432-1033.1992.tb16705.x.
4
Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor.分散因子和肝细胞生长因子是MET受体难以区分的配体。
EMBO J. 1991 Oct;10(10):2867-78. doi: 10.1002/j.1460-2075.1991.tb07836.x.
5
Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.正常及恶性细胞中肝细胞生长因子受体的结构、生物合成及生化特性
EXS. 1993;65:131-65.
6
Isoforms of human HGF and their biological activities.人肝细胞生长因子的异构体及其生物学活性。
EXS. 1993;65:67-79.
7
Identification of the ron gene product as the receptor for the human macrophage stimulating protein.鉴定ron基因产物作为人巨噬细胞刺激蛋白的受体。
Science. 1994 Oct 7;266(5182):117-9. doi: 10.1126/science.7939629.
8
Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET.肝细胞生长因子(HGF)刺激原癌基因c-MET编码的受体的酪氨酸激酶活性。
Oncogene. 1991 Apr;6(4):501-4.
9
Evidence for non-covalent clusters of the c-met proto-oncogene product.
Oncogene. 1992 Jun;7(6):1149-57.
10
The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase.酪氨酸磷酸化的肝细胞生长因子/分散因子受体与磷脂酰肌醇3激酶相关联。
J Biol Chem. 1991 Nov 25;266(33):22087-90.

引用本文的文献

1
Systematic review of c-met as a prognostic indicator in esophageal cancer patients: a meta-analysis study.c-met作为食管癌患者预后指标的系统评价:一项荟萃分析研究
Discov Oncol. 2025 Sep 26;16(1):1716. doi: 10.1007/s12672-025-03398-y.
2
The role and research progress of the MET signalling pathway in targeted therapy for osteosarcoma.MET信号通路在骨肉瘤靶向治疗中的作用及研究进展
Oncol Rev. 2025 Jun 17;19:1615111. doi: 10.3389/or.2025.1615111. eCollection 2025.
3
Neoadjuvant tepotinib in stage IIB N0 non-small cell lung carcinoma with exon 14 skipping mutation: a case report and review of the literature.
新辅助替泊替尼治疗伴有14号外显子跳跃突变的IIB期N0非小细胞肺癌:一例报告并文献复习
Transl Lung Cancer Res. 2025 May 30;14(5):1870-1876. doi: 10.21037/tlcr-2024-1197. Epub 2025 May 21.
4
Identification of Novel Compounds That Bind to the HGF β-Chain In Silico, Verification by Molecular Mechanics and Quantum Mechanics, and Validation of Their HGF Inhibitory Activity In Vitro.通过计算机模拟鉴定与肝细胞生长因子β链结合的新型化合物,利用分子力学和量子力学进行验证,并在体外验证其肝细胞生长因子抑制活性。
Molecules. 2025 Apr 17;30(8):1801. doi: 10.3390/molecules30081801.
5
Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies.解码肿瘤血管生成:抗癌策略中的途径、机制及未来方向
Biomark Res. 2025 Apr 18;13(1):62. doi: 10.1186/s40364-025-00779-x.
6
Mitigation of Methotrexate-Induced Intestinal Mucositis in Male Wistar Rats by Gallic Acid: The Role of HGF and C-Met Genes.没食子酸减轻雄性Wistar大鼠甲氨蝶呤诱导的肠道黏膜炎:HGF和C-Met基因的作用
J Toxicol. 2025 Mar 17;2025:9990692. doi: 10.1155/jt/9990692. eCollection 2025.
7
Characterization of Bozitinib as a potential therapeutic agent for MET-amplified gastric cancer.波齐替尼作为MET扩增型胃癌潜在治疗药物的特性研究
Commun Biol. 2025 Jan 28;8(1):134. doi: 10.1038/s42003-025-07490-5.
8
MET Exon 14 Skipping and Novel Actionable Variants: Diagnostic and Therapeutic Implications in Latin American Non-Small-Cell Lung Cancer Patients.MET外显子14跳跃及新型可靶向变异:对拉丁美洲非小细胞肺癌患者的诊断和治疗意义
Int J Mol Sci. 2024 Dec 22;25(24):13715. doi: 10.3390/ijms252413715.
9
MET amplification correlates with poor prognosis and immunotherapy response as a subtype of melanoma: a multicenter retrospective study.MET 扩增与不良预后和免疫治疗反应相关,是黑色素瘤的一种亚型:一项多中心回顾性研究。
BMC Cancer. 2024 Nov 11;24(1):1384. doi: 10.1186/s12885-024-13163-z.
10
Anti-MET Antibody Therapies in Non-Small-Cell Lung Cancer: Current Progress and Future Directions.非小细胞肺癌中的抗MET抗体疗法:当前进展与未来方向
Antibodies (Basel). 2024 Oct 18;13(4):88. doi: 10.3390/antib13040088.